Secukinumab
5 NDCs across 1 manufacturer|0 Generic,5 Brand
Secukinumab is used to treat psoriatic arthritis and ankylosing spondylitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $1.6 billion on Secukinumab across 178,000 claims for 28,000 beneficiaries.
Secukinumab is available as 5 NDCs from 1 manufacturer (0 generic, 5 brand), with NADAC prices from $3924.35 to $7869.63 per ML — the most expensive product costs about 2.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
0G / 5B
Manufacturers
1
competing in market
Price Spread
$3924.35 – $7869.63
per ML
7d Activity
avg -0.0% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing SECUKINUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
COSENTYX 150 MG/ML SYRINGE | $7869.6275 per ML | -0.08% |
COSENTYX SENSOREADY 150 MG/ML PEN | $7854.3190 per ML | +0.05% |
COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) | $4088.1014 per ML | +0.13% |
COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) | $3941.7995 per ML | +0.08% |
COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES | $3924.3531 per ML | -0.30% |
Frequently Asked Questions
What is Secukinumab used to treat?
Secukinumab is used to treat psoriatic arthritis and ankylosing spondylitis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Secukinumab?
In 2024, Medicare Part D spent $1.6 billion on Secukinumab across 178,000 claims for 28,000 beneficiaries.
How many Secukinumab products are on the market?
The Secukinumab drug market contains 5 NDCs from 1 manufacturer — 0 generic and 5 brand products.
What is the price range for Secukinumab?
NADAC reference prices for Secukinumab range from $3924.3531 to $7869.6275 per ML — the most expensive product costs about 2.0× the cheapest.
Which manufacturers make Secukinumab?
1 manufacturer lists Secukinumab in NADAC. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (5).
How has the price of Secukinumab changed recently?
Over the past 7 days, 3 Secukinumab NDCs rose and 2 fell, with a market-wide average change of -0.0%.